How Ketamine, Psilocybin And Other Psychedelics Are Changing Psychiatric Care : Short Wave Psychedelics like ketamine and psilocybin are getting a second look as a way to treat psychiatric problems like depression, anxiety, substance use disorders, even PTSD. NPR neuroscience correspondent Jon Hamilton explains how these drugs are helping brain scientists understand what causes mental illness and find new ways to treat it.

Email the show at shortwave@npr.org.

The Resurgence Of Psychedelic Psychiatry

The Resurgence Of Psychedelic Psychiatry

  • Download
  • <iframe src="https://www.npr.org/player/embed/985317816/985554956" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
San Francisco Chronicle/Hearst Newspapers
Dr. M. Rameen Ghorieshi is preparing to give his patient a ketamine IV at his clinic in Palo Alto, Calif. A ketamine-based nasal spray treatment was approved by the FDA in 2019.
San Francisco Chronicle/Hearst Newspapers

Psychedelics like ketamine and psilocybin are getting a second look as a way to treat psychiatric problems like depression, anxiety, substance use disorders, even PTSD. NPR neuroscience correspondent Jon Hamilton explains how these drugs are helping brain scientists understand what causes mental illness and find new ways to treat it.

Email the show at shortwave@npr.org.

This episode was fact-checked by Rasha Aridi, and edited by Gisele Grayson.